Management
The Executive Board
Dr. Matthias Schroff
Chief Executive Officer
is a well-known scientist and has been employed by MOLOGEN AG since 1998. Dr. Schroff is co-inventor of numerous MOLOGEN AG technologies. While a student, he worked in close cooperation with Professor Dr. Wittig, former CEO and co-founder of MOLOGEN AG. With a Ph.D. in biochemistry, Dr. Matthias Schroff first worked as a leading scientist, before moving into management. Since 2005, he has been a member of the Board of Directors.
As of January 1, 2008, Dr. Schroff was appointed as CEO at MOLOGEN AG and is responsible for Research and Development, Strategy and Partnering.
Joerg Petrass
Chief Financial Officer
has been at MOLOGEN AG since 2001 and worked as a leading manager in administration and accounting. His detailed knowledge about business at MOLOGEN AG is combined with extensive expertise in designing industry-specific contracts. In addition, he has many years of experience in accounting and extensive knowledge on capital market regulations.
Jörg Petraß has been a member of the Board of Directors since 2007 and is responsible for Finances, Investor Relations, Administration and Human Resources.
|
|
NEWS
|
June 22, 2010
MOLOGEN AG receives approval for clinical study with cell-based gene therapy against renal cancer
press release
ad-hoc announcement
|

|
June 22, 2010
MOLOGEN AG starts phase 2 clinical study with DNA-based cancer medicine MGN1703 against colorectal cancer
more
|
NEWSLETTER |
| To subscribe to our Newsletter please
click here
|
|
|